Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,950 | -56,584 | -67,883 | -63,344 | -53,088 |
| Depreciation Amortization | 829 | 13 | -1,262 | -226 | 497 |
| Accounts receivable | -2,042 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,050 | 711 | -595 | 163 | 543 |
| Other Working Capital | 6,958 | -544 | -2,140 | 509 | -3,429 |
| Other Operating Activity | 17,541 | 20,908 | 20,644 | 16,383 | 23,232 |
| Operating Cash Flow | $-18,714 | $-35,496 | $-51,236 | $-46,515 | $-32,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,942 | 20,077 | 31,089 | -70,817 | N/A |
| PPE Investments | -88 | -268 | -1,229 | -1,619 | -506 |
| Investing Cash Flow | $-7,030 | $19,809 | $29,860 | $-72,436 | $-506 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 29,574 | N/A |
| Debt Repayment | -20,722 | -5,000 | N/A | N/A | -4,568 |
| Common Stock Issued | 61,081 | 18,632 | 395 | 317 | 73,674 |
| Other Financing Activity | -59 | -47 | -162 | -886 | 8,040 |
| Financing Cash Flow | $40,300 | $13,585 | $233 | $29,005 | $77,146 |
| Beginning Cash Position | 4,262 | 6,364 | 27,507 | 117,453 | 73,058 |
| End Cash Position | 18,818 | 4,262 | 6,364 | 27,507 | 117,453 |
| Net Cash Flow | $14,556 | $-2,102 | $-21,143 | $-89,946 | $44,395 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,714 | -35,496 | -51,236 | -46,515 | -32,245 |
| Capital Expenditure | -88 | -268 | -1,229 | -1,619 | -506 |
| Free Cash Flow | -18,802 | -35,764 | -52,465 | -48,134 | -32,751 |